Literature DB >> 11642603

CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB.

G K Koski1, L A Lyakh, P A Cohen, N R Rice.   

Abstract

Dendritic cells are extremely potent antigen-presenting cells that are primarily responsible for the sensitization of naïve T cells to protein antigen in vivo. For this reason, dendritic cells are the focus of intense study. Despite this interest, relatively little information is available on the signal transduction pathways that regulate the development and activity of these cells. The last several years, however, have seen a steady accumulation of data regarding methods to cultivate large numbers of DC, the characterization of attendant signals that drive DC development from various precursor cells, and the induction of nuclear transcription factors that presumably direct alterations in gene expression that regulate aspects of DC development. In this review, we briefly summarize some of these findings, with emphasis on monocyte-derived dendritic cells and a discussion of two distinct types of signaling pathways that appear to regulate the final maturation of DC: one pathway calcium-dependent and cyclosporine A-sensitive, the other pathway CsA-insensitive. Although evidence suggests these signaling pathways are quite divergent in their upstream components, they both appear to activate NF-kappaB nuclear factors, particularly RelB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11642603

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  12 in total

1.  Flt3 ligand generates morphologically distinct semimature dendritic cells in ovalbumin-sensitized mice.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-12-19       Impact factor: 3.362

Review 2.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 4.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

5.  Immunoregulatory effects of the flavonol quercetin in vitro and in vivo.

Authors:  Thomas Nickel; Henner Hanssen; Zeljka Sisic; Susanne Pfeiler; Claudia Summo; Daniel Schmauss; Eva Hoster; Michael Weis
Journal:  Eur J Nutr       Date:  2010-07-23       Impact factor: 5.614

6.  Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases.

Authors:  Nagendra Singh; Muthusamy Thangaraju; Puttur D Prasad; Pamela M Martin; Nevin A Lambert; Thomas Boettger; Stefan Offermanns; Vadivel Ganapathy
Journal:  J Biol Chem       Date:  2010-07-02       Impact factor: 5.157

7.  Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes.

Authors:  Xiuqing Wang; Martin Messerle; Ramil Sapinoro; Kathlyn Santos; Peter K Hocknell; Xia Jin; Stephen Dewhurst
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

8.  Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.

Authors:  Y Qu; J L Taylor; A Bose; W J Storkus
Journal:  Cancer Gene Ther       Date:  2011-07-15       Impact factor: 5.987

9.  The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function.

Authors:  Bernhard M Kirsch; Maximilian Zeyda; Karl Stuhlmeier; Johannes Grisar; Josef S Smolen; Bruno Watschinger; Thomas M Stulnig; Walter H Hörl; Gerhard J Zlabinger; Marcus D Säemann
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

10.  TLR3 and TLR4 expression in healthy and diseased human endometrium.

Authors:  Svenja Allhorn; Carsten Böing; Andrea A Koch; Rainer Kimmig; Isabella Gashaw
Journal:  Reprod Biol Endocrinol       Date:  2008-09-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.